PubMed:24756758
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-132 | Sentence | denotes | Association of endothelia nitric oxide synthase gene rs1799983 polymorphism with susceptibility to prostate cancer: a meta-analysis. |
| TextSentencer_T2 | 133-312 | Sentence | denotes | Genetic polymorphism of endothelial nitric oxide synthase (NOS3) rs1799983 (Glu298Asp) has been implicated to alter the risk of prostate cancer, but the results are controversial. |
| TextSentencer_T3 | 313-441 | Sentence | denotes | Two investigators independently searched the PubMed, Cochrane Library, and Embase electronic databases up to September 30, 2013. |
| TextSentencer_T4 | 442-564 | Sentence | denotes | Summary odds ratios (OR) and 95 % confidence interval (CI) for rs1799983 polymorphism and prostate cancer were calculated. |
| TextSentencer_T5 | 565-668 | Sentence | denotes | Statistical analysis was performed with the software program Review Manage, version 5.0 and Stata 11.0. |
| TextSentencer_T6 | 669-761 | Sentence | denotes | A total of 7 independent studies, including 1,792 cases and 2,411 controls, were identified. |
| TextSentencer_T7 | 762-984 | Sentence | denotes | Our analysis suggested that rs1799983 was associated with prostate cancer risk in overall population under dominant model (OR = 1.15, 95%CI = 1.01-1.30, P = 0.03) and allelic model (OR = 1.11, 95%CI = 1.00-1.22, P = 0.04). |
| TextSentencer_T8 | 985-1140 | Sentence | denotes | In the subgroup analysis, we detected no association between rs1799983 polymorphism and prostate risk in Caucasian population under all the genetic models. |
| TextSentencer_T9 | 1141-1294 | Sentence | denotes | This meta-analysis showed the evidence that NOS3 rs1799983 polymorphism was associated with a risk of prostate cancer development in overall populations. |
| T1 | 0-132 | Sentence | denotes | Association of endothelia nitric oxide synthase gene rs1799983 polymorphism with susceptibility to prostate cancer: a meta-analysis. |
| T2 | 133-312 | Sentence | denotes | Genetic polymorphism of endothelial nitric oxide synthase (NOS3) rs1799983 (Glu298Asp) has been implicated to alter the risk of prostate cancer, but the results are controversial. |
| T3 | 313-441 | Sentence | denotes | Two investigators independently searched the PubMed, Cochrane Library, and Embase electronic databases up to September 30, 2013. |
| T4 | 442-564 | Sentence | denotes | Summary odds ratios (OR) and 95 % confidence interval (CI) for rs1799983 polymorphism and prostate cancer were calculated. |
| T5 | 565-668 | Sentence | denotes | Statistical analysis was performed with the software program Review Manage, version 5.0 and Stata 11.0. |
| T6 | 669-761 | Sentence | denotes | A total of 7 independent studies, including 1,792 cases and 2,411 controls, were identified. |
| T7 | 762-984 | Sentence | denotes | Our analysis suggested that rs1799983 was associated with prostate cancer risk in overall population under dominant model (OR = 1.15, 95%CI = 1.01-1.30, P = 0.03) and allelic model (OR = 1.11, 95%CI = 1.00-1.22, P = 0.04). |
| T8 | 985-1140 | Sentence | denotes | In the subgroup analysis, we detected no association between rs1799983 polymorphism and prostate risk in Caucasian population under all the genetic models. |
| T9 | 1141-1294 | Sentence | denotes | This meta-analysis showed the evidence that NOS3 rs1799983 polymorphism was associated with a risk of prostate cancer development in overall populations. |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 157-190 | gene:4846 | denotes | endothelial nitric oxide synthase |
| T1 | 261-276 | disease:C0376358 | denotes | prostate cancer |
| T2 | 157-190 | gene:4846 | denotes | endothelial nitric oxide synthase |
| T3 | 261-276 | disease:C0600139 | denotes | prostate cancer |
| T4 | 192-196 | gene:4846 | denotes | NOS3 |
| T5 | 261-276 | disease:C0376358 | denotes | prostate cancer |
| T6 | 192-196 | gene:4846 | denotes | NOS3 |
| T7 | 261-276 | disease:C0600139 | denotes | prostate cancer |
| R1 | T0 | T1 | associated_with | endothelial nitric oxide synthase,prostate cancer |
| R2 | T2 | T3 | associated_with | endothelial nitric oxide synthase,prostate cancer |
| R3 | T4 | T5 | associated_with | NOS3,prostate cancer |
| R4 | T6 | T7 | associated_with | NOS3,prostate cancer |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 261-276 | HP_0012125 | denotes | prostate cancer |
| T2 | 270-276 | HP_0002664 | denotes | cancer |
| T3 | 532-547 | HP_0012125 | denotes | prostate cancer |
| T4 | 541-547 | HP_0002664 | denotes | cancer |
| T5 | 820-835 | HP_0012125 | denotes | prostate cancer |
| T6 | 829-835 | HP_0002664 | denotes | cancer |
| T7 | 1243-1258 | HP_0012125 | denotes | prostate cancer |
| T8 | 1252-1258 | HP_0002664 | denotes | cancer |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_24756758_3_0 | 450-461 | expanded | denotes | odds ratios |
| SS2_24756758_3_0 | 463-465 | abbr | denotes | OR |
| SS1_24756758_3_1 | 476-495 | expanded | denotes | confidence interval |
| SS2_24756758_3_1 | 497-499 | abbr | denotes | CI |
| AE1_24756758_3_0 | SS1_24756758_3_0 | SS2_24756758_3_0 | abbreviatedTo | odds ratios,OR |
| AE1_24756758_3_1 | SS1_24756758_3_1 | SS2_24756758_3_1 | abbreviatedTo | confidence interval,CI |
DisGeNET5_variant_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 24756758-0#53#62#geners1799983 | 53-62 | geners1799983 | denotes | rs1799983 |
| 24756758-0#99#114#diseaseC0376358 | 99-114 | diseaseC0376358 | denotes | prostate cancer |
| 24756758-0#99#114#diseaseC0600139 | 99-114 | diseaseC0600139 | denotes | prostate cancer |
| 53#62#geners179998399#114#diseaseC0376358 | 24756758-0#53#62#geners1799983 | 24756758-0#99#114#diseaseC0376358 | associated_with | rs1799983,prostate cancer |
| 53#62#geners179998399#114#diseaseC0600139 | 24756758-0#53#62#geners1799983 | 24756758-0#99#114#diseaseC0600139 | associated_with | rs1799983,prostate cancer |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 24756758-8#44#48#gene4846 | 1185-1189 | gene4846 | denotes | NOS3 |
| 24756758-8#102#117#diseaseC0376358 | 1243-1258 | diseaseC0376358 | denotes | prostate cancer |
| 24756758-8#102#117#diseaseC0600139 | 1243-1258 | diseaseC0600139 | denotes | prostate cancer |
| 44#48#gene4846102#117#diseaseC0376358 | 24756758-8#44#48#gene4846 | 24756758-8#102#117#diseaseC0376358 | associated_with | NOS3,prostate cancer |
| 44#48#gene4846102#117#diseaseC0600139 | 24756758-8#44#48#gene4846 | 24756758-8#102#117#diseaseC0600139 | associated_with | NOS3,prostate cancer |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T178 | 1185-1189 | gene:4846 | denotes | NOS3 |
| T179 | 1243-1258 | disease:C0376358 | denotes | prostate cancer |
| R1 | T178 | T179 | associated_with | NOS3,prostate cancer |
| R2 | T178 | T179 | associated_with | NOS3,prostate cancer |
PubTator4TogoVar
| Id | Subject | Object | Predicate | Lexical cue | resolved_to |
|---|---|---|---|---|---|
| 2 | 53-62 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
| 19 | 198-207 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
| 22 | 505-514 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
| 24 | 790-799 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
| 26 | 1046-1055 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
| 28 | 1190-1199 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
PubTatorOnTogoVar
| Id | Subject | Object | Predicate | Lexical cue | resolved_to |
|---|---|---|---|---|---|
| 2 | 53-62 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
| 19 | 198-207 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
| 22 | 505-514 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
| 24 | 790-799 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
| 26 | 1046-1055 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
| 28 | 1190-1199 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
| T1 | 53-62 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606|tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
| T1 | 198-207 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606|tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
| T2 | 505-514 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
| T3 | 790-799 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
| T4 | 1046-1055 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |
| T5 | 1190-1199 | SNP | denotes | rs1799983 | tmVar:rs1799983;VariantGroup:0;CorrespondingGene:4846;RS#:1799983;CorrespondingSpecies:9606 |